Beijing Datsing Bio-tech Co., Ltd. Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2001

Location

Beijing China

Primary Industry

Biotechnology

About

Based in Beijing, China, Beijing Datsing Bio-tech Co., Ltd. is a biotechnology that focuses on the research and development of regenerative medicine materials. In 2014, the firm closed a series A funding. In 2007, the company acquired medical device quality management system certifications ISO 9001:2008 and ISO13485:2003. In 2019, it established Beijing Kejian Technology Co., Ltd. As of 2023, Beijing Datsing Bio-tech Co., Ltd. owns 59 intellectual property rights. The company's main products include clear biopaper, No. 1 dental implants and tooth desensitizer Aominqing, etc. Aominqing has the functions of relieving and reducing gum bleeding, inhibiting and reducing dental plaque. The company's products are used in minimally invasive surgery, oral medicine, and regenerative medicine.

Current Investors

Tsinghua Innovation Ventures, NLVC, Hidea Investment

Request a demo to show more

Primary Industry

Biotechnology

Sub Industries

Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Medical Supplies

Website

www.datsing.com

Verticals

HealthTech

Company Stage

Series A

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.